Literature DB >> 19657545

Efficient risk set sampling when a time-dependent exposure is present: matching for time to exposure versus exposure density sampling.

Martin Wolkewitz1, J Beyersmann, P Gastmeier, M Schumacher.   

Abstract

OBJECTIVES: The impact of time-dependent exposures on the time until study endpoint may correctly be analyzed with data of a full cohort. Ignoring the time-dependent nature of these exposures leads to time-dependent bias. Matching for time to exposure is often applied to take the time-dependency into account, but prefixed sets of exposed and unexposed may still create bias. This approach is attractive since a subcohort would also save resources, especially when exposure and outcome data are only available in the full cohort but further covariate information is required. The first objective is to show to which extent matching for time to exposure yields biased results. Secondly, exposure density sampling is introduced and explored.
METHODS: To evaluate how both sampling methods perform, they are compared to the correct method as well as to the approach in which the time-dependent nature of the exposure is ignored. Real data of the SIR-3 study (Germany, 2000-2001) and a simulation study are used.
RESULTS: Simulations show that matching may reduce the time-dependent bias but still there is a bias. The matching bias decreases if fewer patients are exposed. Exposure density sampling yields unbiased results.
CONCLUSIONS: Results from studies in which matching for time to exposure was applied are only tolerable for rare exposures. Whenever subcohorting is the intention in order to save resources, exposure density sampling should be preferred instead.

Entities:  

Mesh:

Year:  2009        PMID: 19657545     DOI: 10.3414/ME9241

Source DB:  PubMed          Journal:  Methods Inf Med        ISSN: 0026-1270            Impact factor:   2.176


  10 in total

1.  Nested exposure case-control sampling: a sampling scheme to analyze rare time-dependent exposures.

Authors:  Jan Feifel; Madlen Gebauer; Martin Schumacher; Jan Beyersmann
Journal:  Lifetime Data Anal       Date:  2018-11-13       Impact factor: 1.588

2.  The impact of hospital-acquired infections on the patient-level reimbursement-cost relationship in a DRG-based hospital payment system.

Authors:  Klaus Kaier; Martin Wolkewitz; Philip Hehn; Nico T Mutters; Thomas Heister
Journal:  Int J Health Econ Manag       Date:  2019-06-05

3.  Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections.

Authors:  Marlieke E A de Kraker; Martin Wolkewitz; Peter G Davey; Walter Koller; Jutta Berger; Jan Nagler; Claudine Icket; Smilja Kalenic; Jasminka Horvatic; Harald Seifert; Achim J Kaasch; Olga Paniara; Athina Argyropoulou; Maria Bompola; Edmond Smyth; Mairead Skally; Annibale Raglio; Uga Dumpis; Agita Melbarde Kelmere; Michael Borg; Deborah Xuereb; Mihaela C Ghita; Michelle Noble; Jana Kolman; Stanko Grabljevec; David Turner; Louise Lansbury; Hajo Grundmann
Journal:  Antimicrob Agents Chemother       Date:  2011-01-10       Impact factor: 5.191

4.  The increased risks of death and extra lengths of hospital and ICU stay from hospital-acquired bloodstream infections: a case-control study.

Authors:  Adrian G Barnett; Katie Page; Megan Campbell; Elizabeth Martin; Rebecca Rashleigh-Rolls; Kate Halton; David L Paterson; Lisa Hall; Nerina Jimmieson; Katherine White; Nicholas Graves
Journal:  BMJ Open       Date:  2013-10-31       Impact factor: 2.692

Review 5.  Surveillance strategies using routine microbiology for antimicrobial resistance in low- and middle-income countries.

Authors:  Cherry Lim; Elizabeth A Ashley; Raph L Hamers; Paul Turner; Thomas Kesteman; Samuel Akech; Alejandra Corso; Mayfong Mayxay; Iruka N Okeke; Direk Limmathurotsakul; H Rogier van Doorn
Journal:  Clin Microbiol Infect       Date:  2021-06-07       Impact factor: 13.310

6.  Mortality, Length of Stay, and Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Elderly Hospitalized Patients in the United States.

Authors:  Richard E Nelson; David Hyun; Amanda Jezek; Matthew H Samore
Journal:  Clin Infect Dis       Date:  2022-03-23       Impact factor: 9.079

7.  Costs of hospital-acquired Clostridium difficile infections: an analysis on the effect of time-dependent exposures using routine and surveillance data.

Authors:  Thomas Heister; Martin Wolkewitz; Philip Hehn; Jan Wolff; Markus Dettenkofer; Hajo Grundmann; Klaus Kaier
Journal:  Cost Eff Resour Alloc       Date:  2019-08-01

8.  In-hospital costs of community-acquired colonization with multidrug-resistant organisms at a German teaching hospital.

Authors:  Sabine Engler-Hüsch; Thomas Heister; Nico T Mutters; Jan Wolff; Klaus Kaier
Journal:  BMC Health Serv Res       Date:  2018-09-26       Impact factor: 2.655

9.  Measuring the in-hospital costs of Pseudomonas aeruginosa pneumonia: methodology and results from a German teaching hospital.

Authors:  Klaus Kaier; Thomas Heister; Tim Götting; Martin Wolkewitz; Nico T Mutters
Journal:  BMC Infect Dis       Date:  2019-12-03       Impact factor: 3.090

10.  Burden of Antimicrobial Resistance: Compared to What?

Authors:  Marlieke E A de Kraker; Marc Lipsitch
Journal:  Epidemiol Rev       Date:  2022-01-14       Impact factor: 6.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.